<description>&lt;p&gt;From the recent paper from Furyk in the EMJ on oral and i.v. paracetamol, does the fact that the study was underpowered mean a greater chance of a type 2 error?&lt;/p&gt; &lt;p style="text-align: center;"&gt;&lt;strong&gt;References and relevant resources&lt;/strong&gt;&lt;/p&gt; &lt;p style="text-align: center;"&gt;&lt;a href= "http://theresusroom.co.uk/papers-of-january-18"&gt;http://&lt;/a&gt;&lt;a href="http://www.CriticalAppraisalLowdown.co.uk"&gt;CriticalAppraisalLowdown.co.uk&lt;/a&gt;&lt;/p&gt; &lt;p style="text-align: center;"&gt;&lt;a href= "http://theresusroom.co.uk/papers-of-january-18"&gt;http://theresusroom.co.uk/papers-of-january-18&lt;/a&gt;&lt;/p&gt; &lt;p&gt; &lt;/p&gt;</description>

Critical Appraisal Lowdown

Unknown

Underpowered studies & type 2 error

JAN 1, 20183 MIN
Critical Appraisal Lowdown

Underpowered studies & type 2 error

JAN 1, 20183 MIN

Description

From the recent paper from Furyk in the EMJ on oral and i.v. paracetamol, does the fact that the study was underpowered mean a greater chance of a type 2 error? References and relevant resources http://CriticalAppraisalLowdown.co.uk http://theresusroom.co.uk/papers-of-january-18